相关实验视频
Updated: Jan 11, 2026
06:51
Mouse Model of Pressure Ulcers After Spinal Cord Injury
Published on: March 9, 2019
10.0K
对压力的必需氨基酸补充:病理生理学理由和试点研究结果
Maciej Świątkiewicz1, Andrzej Lejczak2, Piotr Foltyński3
1Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawinskiego 5, Warsaw, 02-106, Poland. mswiatkiewicz@imdik.pan.pl.
Amino acids
|November 14, 2025
概括
这项研究研究了一种新的食补充剂,用于治疗压力 (PU). 与对照组相比,接受histidine,typtophan和threonine的患者显示PU面积显著减少.
科学领域:
- 伤口治愈研究研究 伤口治愈研究
- 营养科学 营养科学
- 皮肤病学 皮肤病学
背景情况:
- 压力 (PU) 是一个重要的健康问题,通常与营养不良有关.
- 目前的PU治疗可能不适合患有慢性病的患者,因为蛋白质含量高.
- 在PU患者中观察到特定的氨基酸缺乏 (histidine,tryptophan,threonine).
研究的目的:
- 评估一种新型食品成分 (Pellicar-F) 的有效性,该成分含有histidine,tryptophan和threonine,用于压力的治疗.
- 评估这种特定氨基酸补充剂对PU患者伤口愈合的影响.
主要方法:
- 进行了一项具有准实验设计的试点临床试验.
- 患者每天服用Pellicar-F,这是一种含有histidine (作为carnosine),tryptophan和threonine的专有成分.
- 对照组接受了标准的护理.
主要成果:
- 补充Pellicar-F的患者在六周后显示压力区域的统计显著减少.
- 与对照组相比,干预组的结果有所改善.
结论:
- 被测试的含有histidine,typtophan和threonine的食品成分显示出改善压力潰瘍愈合的承诺.
- 需要对佩利卡尔-F用于压力和其他慢性伤口的进一步研究.
相关概念视频
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.1K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.1K
01:28Peptic Ulcer Disease II: Pathophysiology
1.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
01:26Peptic Ulcer Disease IV: Management
419
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
419
01:30Peptic Ulcer Disease I: Introduction
722
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
722
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K